LBA75 Prospective randomised phase-II trial of ipilimumab/nivolumab versus standard of care in non-clear cell renal cell cancer: Results of the SUNNIFORECAST trial. - Bergmann, L.; Ahrens, M.; Albiges, L.; Gross Goupil, M.; Boleti, E.; Gravis, G.; Flechon, A.; Grimm, M-O.J.; Rausch, S.; Barthelemy, P.; Castellano Gauna, D.E.; Mellado Gonzalez, B.; et al. (Annals of Oncology, 2024)